These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7534919)

  • 1. Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.
    Murphy GP; Holmes EH; Boynton AL; Kenny GM; Ostenson RC; Erickson SJ; Barren RJ
    Prostate; 1995 Mar; 26(3):164-8. PubMed ID: 7534919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients.
    Rochon YP; Horoszewicz JS; Boynton AL; Holmes EH; Barren RJ; Erickson SJ; Kenny GM; Murphy GP
    Prostate; 1994 Oct; 25(4):219-23. PubMed ID: 8084837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
    Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
    Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.
    Cama C; Olsson CA; Raffo AJ; Perlman H; Buttyan R; O'Toole K; McMahon D; Benson MC; Katz AE
    J Urol; 1995 May; 153(5):1373-8. PubMed ID: 7536252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer.
    Murphy GP; Kenny GM; Ragde H; Wolfert RL; Boynton AL; Holmes EH; Misrock SL; Bartsch G; Klocker H; Pointner J; Reissigl A; McLeod DG; Douglas T; Morgan T; Gilbaugh J
    Urology; 1998 May; 51(5A Suppl):89-97. PubMed ID: 9610563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the prostate-specific membrane antigen.
    Israeli RS; Powell CT; Corr JG; Fair WR; Heston WD
    Cancer Res; 1994 Apr; 54(7):1807-11. PubMed ID: 7511053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage.
    Grasso YZ; Gupta MK; Levin HS; Zippe CD; Klein EA
    Cancer Res; 1998 Apr; 58(7):1456-9. PubMed ID: 9537248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
    Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ
    Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients.
    Murphy G; Ragde H; Kenny G; Barren R; Erickson S; Tjoa B; Boynton A; Holmes E; Gilbaugh J; Douglas T
    Anticancer Res; 1995; 15(4):1473-9. PubMed ID: 7544569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.
    Koutsilieris M; Lembessis P; Luu-The V; Sourla A
    Clin Exp Metastasis; 1999; 17(10):823-30. PubMed ID: 11089880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of an enzyme-linked immunoassay for the prostate: specific antigen utilizing two monoclonal antibodies.
    Zundel D; Jarry H; Kestler D; Holzapfel G; Bartels H; Scheit KH; Wuttke W
    Urol Res; 1990; 18(5):327-30. PubMed ID: 1701585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer.
    Okegawa T; Yoshioka J; Morita R; Nutahara K; Tsukada Y; Higashihara E
    Int J Urol; 1998 Jul; 5(4):349-56. PubMed ID: 9712443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
    Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD
    Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer.
    Beckett ML; Cazares LH; Vlahou A; Schellhammer PF; Wright GL
    Clin Cancer Res; 1999 Dec; 5(12):4034-40. PubMed ID: 10632336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients.
    Horoszewicz JS; Kawinski E; Murphy GP
    Anticancer Res; 1987; 7(5B):927-35. PubMed ID: 2449118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
    Douglas TH; Morgan TO; McLeod DG; Moul JW; Murphy GP; Barren R; Sesterhenn IA; Mostofi FK
    Cancer; 1997 Jul; 80(1):107-14. PubMed ID: 9210715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of expression of PSA, hK2, PSMA in the peripheral blood of patients with prostate cancer].
    Cui WG; Zhao H; Song YZ; Zhang J; Zhang LG; Shi JD; Qiang WM
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):479-81. PubMed ID: 15555338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy.
    Marrink J; Oosterom R; Bonfrer HM; Schröder FH; Mensink HJ
    Eur J Cancer; 1993; 29A(4):570-1. PubMed ID: 7679580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.